Back to Latest SignalTECHMEME / MODEL RELEASE

London-based Boltz, which is developing AI models to speed up drug discovery, raised a $110M Series A led by Bessemer, after raising a $28M seed in 2025 (John Reynolds/Tech.eu)

Source: TECHMEME · NOV 19, 2026

John Reynolds / Tech.eu : London-based Boltz, which is developing AI models to speed up drug discovery, raised a $110M Series A led by Bessemer, after raising a $28M seed in 2025 — Boltz was spun out of MIT but is now located in London. — London-based AI drug discovery startup Boltz has raised a $110m Series A funding round …

IN THIS STORY
  • AI drug discovery
  • Bessemer Venture Partners

Sources

  • Read the original at TECHMEME

Related on Frontier

  • LanceDB, which makes a multimodal lakehouse for AI training, built on the open format Lance, raised a $57.5M Series B led by Bessemer and Innovation Endeavors (Kyt Dotson/SiliconANGLE) Nov 17, 2026
  • China AI Biotech Firm Raises $200 Million in Oman-Backed Round Nov 18, 2026
  • Paris-based Remanence, which helps companies train and fine-tune open-weight AI models, raised a $30M seed led by EQT Ventures and FirstMark (Lucinda Shen/Axios) Nov 18, 2026
MORE LATEST SIGNALSIGNALS